Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruili Huang

Showing results (1-10 of 244) with videos related to

Pageof 25
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2016
A Quantitative High-Throughput Screening Data Analysis Pipeline for Activity ProfilingRuili Huang
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2022
A Quantitative High-Throughput Screening Data Analysis Pipeline for Activity ProfilingRuili Huang
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2016
Correction of Microplate Data from High-Throughput ScreeningYuhong Wang, Ruili Huang
The Journal of Organic Chemistry|October 25, 2001
A Convenient Preparation of Sulfines (R(2)C=S=O) from ThioketonesRuili Huang, James H. Espenson
Cancer Cell International|September 18, 2020
XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent wayRuili Huang, Lijuan Zhu, Yali Zhang
Frontiers in Pharmacology|August 1, 2022
Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related PathwaysSrilatha Sakamuru, Ruili Huang, Menghang Xia
Drug Discovery Today|May 28, 2021
High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directionsTuan Xu, Wei Zheng, Ruili Huang
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 9, 2015
Discovery of Transcriptional Targets Regulated by Nuclear Receptors Using a Probabilistic Graphical ModelMikyung Lee, Ruili Huang, Weida Tong
Genomics|January 3, 2006
Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screenRuili Huang, Anders Wallqvist, David G Covell
Molecular Cancer Therapeutics|August 19, 2007
Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening dataDavid G Covell, Ruili Huang, Anders Wallqvist
Pageof 25

Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2016
A Quantitative High-Throughput Screening Data Analysis Pipeline for Activity ProfilingRuili Huang
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2022
A Quantitative High-Throughput Screening Data Analysis Pipeline for Activity ProfilingRuili Huang
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2016
Correction of Microplate Data from High-Throughput ScreeningYuhong Wang, Ruili Huang
The Journal of Organic Chemistry|October 25, 2001
A Convenient Preparation of Sulfines (R(2)C=S=O) from ThioketonesRuili Huang, James H. Espenson
Cancer Cell International|September 18, 2020
XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent wayRuili Huang, Lijuan Zhu, Yali Zhang
Frontiers in Pharmacology|August 1, 2022
Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related PathwaysSrilatha Sakamuru, Ruili Huang, Menghang Xia
Drug Discovery Today|May 28, 2021
High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directionsTuan Xu, Wei Zheng, Ruili Huang
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 9, 2015
Discovery of Transcriptional Targets Regulated by Nuclear Receptors Using a Probabilistic Graphical ModelMikyung Lee, Ruili Huang, Weida Tong
Genomics|January 3, 2006
Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screenRuili Huang, Anders Wallqvist, David G Covell
Molecular Cancer Therapeutics|August 19, 2007
Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening dataDavid G Covell, Ruili Huang, Anders Wallqvist
Pageof 25